文献速递外周动脉疾病

胰岛素依赖而非HbA1c或是糖尿病合并慢性肢体威胁性缺血患者腹股沟下旁路术后30天并发症更差的标志

Insulin Dependency Rather Than HbA1c May Be a Hallmark for Worse 30-Day Complications for Diabetes Mellitus Patients with Chronic Limb-Threatening Ischemia Undergoing Infrainguinal Bypass.
PubMed 文献 · Ann Vasc Surg · 2025-07-08

结果显示胰岛素使用组肾脏并发症发生率显著更高(7.60% vs. 3.31%,aOR 2.67,95%CI 1.27-5.60,P=0.01),而死亡率与截肢率无显著差异,且调整HbA1c后结果一致。结论提示胰岛素依赖而非HbA1c是术后30天并发症更差的标志。

要点

  • 胰岛素依赖的糖尿病合并慢性肢体威胁性缺血患者旁路术后肾脏并发症风险显著增加。
  • 胰岛素使用与死亡率、截肢率无显著关联,但其他并发症有升高趋势。
  • HbA1c调整与否不影响胰岛素依赖与结局的关联。

核心结论

  • 胰岛素依赖而非HbA1c是糖尿病合并慢性肢体威胁性缺血患者旁路术后30天并发症更差的标志。

主要发现

  • 胰岛素使用组与非使用组死亡率相似(2.66% vs. 2.11%,aOR 0.73,95%CI 0.27-1.97,P=0.66)。
  • 截肢率两组相似(3.61% vs. 3.92%,aOR 0.84,95%CI 0.38-1.89,P=0.85)。
  • 肾脏并发症胰岛素使用组更常见(7.60% vs. 3.31%,aOR 2.67,95%CI 1.27-5.60,P=0.01)。
  • 其他并发症包括主要不良肢体事件、主要不良心血管事件、脓毒症和需要输血的出血在胰岛素使用组更常见但无统计学显著性。
  • 无论是否调整HbA1c,结果保持一致。

临床怎么用

  • 对于胰岛素依赖的糖尿病合并慢性肢体威胁性缺血患者,应加强术后肾脏并发症监测。
  • 关注需要输血的出血风险,尽管未达统计学显著性。
  • 识别其他可改变因素以改善胰岛素依赖患者的结局。

局限性

  • 回顾性研究设计。
  • 仅使用ACS NSQIP数据库,可能存在未测量混杂。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The relationship between insulin use and clinical outcomes in patients with chronic-limb threatening ischemia remains unclear. This study evaluates differences between patients with diabetes mellitus (DM) stratified by insulin use, revealing potential outcome disparities following bypass procedures. METHODS: Thirty-day outcome data was collected retrospectively from a cohort of chronic-limb threatening ischemia patients with DM following bypass procedures between 2011 and 2022 using the American College of Surgeons National Surgical Quality Improvement Program. Participants were divided into 2 groups based on insulin use. Multivariable analysis controlled for confounders and compared 30-day outcomes. A separate analysis without controlling for hemoglobin A1c (HbA1c) was conducted to examine its impact. RESULTS: Eight hundred fifty-eight patients were included. Mortality was similar between insulin users and noninsulin users (2.66% vs. 2.11%, adjusted odds ratios (aORs) 0.73, 95% confidence interval (CI) 0.27-1.97, P = 0.66), as were amputation rates (3.61% vs. 3.92%, aOR 0.84, 95% CI 0.38-1.89, P = 0.85). Renal complications occurred more frequently in insulin users compared to noninsulin users (7.60% vs. 3.31%, aOR 2.67, 95% CI 1.27-5.60, P = 0.01). Other complications, including major adverse limb events, major adverse cardiovascular events, sepsis, and bleeding requiring transfusion were more common in insulin users but were not statistically significant. Outcomes remained consistent regardless of HbA1c adjustment. CONCLUSION: Insulin dependency, rather than HbA1c, is a hallmark for worse 30-day complications for DM patients undergoing bypass, with a significantly increased rate of renal complications and a nonsignificant trend toward higher bleeding requiring transfusion. This underscores the need to identify other modifiable factors influencing outcomes in insulin-dependent patients.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Wang JY, Li R, Cohen J, et al. Insulin Dependency Rather Than HbA1c May Be a Hallmark for Worse 30-Day Complications for Diabetes Mellitus Patients with Chronic Limb-Threatening Ischemia Undergoing Infrainguinal Bypass. Ann Vasc Surg. 2025. PMID: 40639710. doi:10.1016/j.avsg.2025.06.041

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。